InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Gray Nancy Ryan, 董事. Director active across 1 company, notably Ligand Pharmaceuticals INC. Aggregated, 8 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €72k. Activity tracked since 4 June 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gray Nancy Ryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
836 股0Common StockSEC:0002001011-26-000096:0
3,556 股@ US$66.1973.9% 占其流量Common StockSEC:0002001011-25-000098:0
1,209 股0Common StockSEC:0002001011-25-000046:0
1,252 股0Common StockSEC:0002001011-24-000056:0
934 股@ US$83.2049100.0% 占其流量Common StockSEC:0002001011-24-000054:0
1,142 股0Common StockSEC:0000886163-23-000043:0
1,004 股0Common StockSEC:0000886163-22-000081:0
630 股0Common StockSEC:0000886163-21-000091:0
8 条申报中的 8 条
About Gray Nancy Ryan
Nancy Ryan Gray is a Board Member at LIGAND PHARMACEUTICALS INC. She plays a key role in the governance of the company, bringing her expertise in biopharmaceuticals. Her role is essential in ensuring compliance and transparency in operations.
